Dr. Michael A. Weber is a preventative cardiologist and hypertension specialist at Downstate College of Medicine of the State University of New York. He has been a leading part of several of the clinical trials that have helped define strategies for optimizing cardiovascular protection for patients with hypertension. He has been involved in drug development beginning with beta blockers and through contemporary angiotensin receptor blockers. He is also active in recent trials investigating device therapy in hypertensive disorders, as well as one of the pioneers in developing ambulatory blood pressure monitoring, a technique now recommended for clinical practice by the major clinical hypertension guideline committees.
His main research interests are in clinical trials of patients at high risk of cardiovascular events or strokes. He is also participating actively in trials in patients with metabolic disorders such as diabetes and kidney disease. Dr. Weber currently serves on the Steering Committees of several national and international clinical trials.
